Research and Development

Medical devices

The Medical Device Segment has completed clinical trials of two new types of devices and have obtained approval from the State Food and Drug Administration. Both devices are the first of their kind to be developed and approved domestically, in line with Golden Meditech's strategy to seek first-mover advantage in new business. The Segment has also begun diversifying its client base away from hospitals into the consumer space. It is currently developing a series of personal health monitoring devices, which will gradually be launched to the retail market for health conscious consumers.

Stem cell research

The Cord Blood Bank Segment's recent expansion into Guangdong will gradually build up critical mass. Customers are requested to pay an initial processing fee and an annual storage fee. As the number of new customers rises, the management expects this Segment to generate strong, recurring cash flow for the Group. The management is actively seeking to expand the cord blood storage services into more regions.

Chinese herbal medicine for the treatment of AIDS

At the Chinese Herbal Medicine Segment, the research team has begun conducting the fourth phase of clinical trials of TangHerb, which will allow the product to be sold as an over-the-counter drug. The management estimates TangHerb will complete its clinical trials in a couple of years, paving the way for distribution nationwide of the product over the counter for easy access by the people living with HIV across the country.